| Literature DB >> 30378731 |
Shaunak S Adkar1,2,3, Chia-Lung Wu1,2, Vincent P Willard4, Amanda Dicks1,2,5, Adarsh Ettyreddy6, Nancy Steward1,2, Nidhi Bhutani7, Charles A Gersbach6, Farshid Guilak1,2,5,4.
Abstract
The differentiation of human induced pluripotent stem cells (hiPSCs) to prescribed cell fates enables the engineering of patient-specific tissue types, such as hyaline cartilage, for applications in regenerative medicine, disease modeling, and drug screening. In many cases, however, these differentiation approaches are poorly controlled and generate heterogeneous cell populations. Here, we demonstrate cartilaginous matrix production in three unique hiPSC lines using a robust and reproducible differentiation protocol. To purify chondroprogenitors (CPs) produced by this protocol, we engineered a COL2A1-GFP knock-in reporter hiPSC line by CRISPR-Cas9 genome editing. Purified CPs demonstrated an improved chondrogenic capacity compared with unselected populations. The ability to enrich for CPs and generate homogenous matrix without contaminating cell types will be essential for regenerative and disease modeling applications. Stem Cells 2019;37:65-76. © AlphaMed Press 2018.Entities:
Keywords: CRISPR-Cas9; Chondrocyte; Chondrogenesis; Differentiation; Genome editing; iPSC
Mesh:
Year: 2018 PMID: 30378731 PMCID: PMC6312762 DOI: 10.1002/stem.2931
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 5.845